Bayer | BAYN - Gewinn Vor Steuern

Aktienkurs
38.05
Täglich Wechseln
1.60 4.39%
Monatlich
-3.39%
Jährlich
59.34%
Q2 Prognose
37.49




Gewinn Vor Steuern Veränderung Datum
Air Liquide EUR 2.38B 126.5M 2025-12
Akzo Nobel EUR 148M 598M 2026-03
Alcon AG USD 264M 19M 2025-12
Amarin USD -852K 7.26M 2025-12
Arkema EUR 60M 23M 2025-09
AstraZeneca USD 3.91B 1.28B 2026-03
BASF EUR 35M 109M 2025-09
Bayer EUR -1.16B 735M 2025-09
Beiersdorf EUR 408.5M 43.5M 2025-06
Corteva USD -370M 2.17B 2025-09
Covestro EUR -9M 20M 2025-09
Essilor EUR 2.45B 1.73B 2025-06
Fresenius EUR 601M 122M 2025-12
Fresenius Medical Care EUR 508.46M 105.89M 2025-12
Genmab DKK 55M 427M 2025-12
Givaudan CHF 642M 292M 2024-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Johnson Matthey GBP 201M 68M 2025-06
Linde USD 2.42B 72M 2025-09
Lonza CHF 624M 197M 2024-12
Merck EUR 1.29B 458.1M 2025-09
Novartis USD 4.64B 445M 2025-12
Nutrien USD 637M 990M 2025-09
Philips EUR 275M 62M 2025-09
PPG Industries USD 389M 167M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
SAP EUR 2.83B 65M 2026-03
Solvay EUR 51M 44M 2025-09
UCB EUR 789M 427M 2025-06
Umicore EUR 27.25M 766.55M 2024-12
Vinci EUR 4.65B 3B 2025-12